Simon Fraser University (SFU) is a public research university in British Columbia, Canada, with three campuses, all in Greater Vancouver: Burnaby, Surrey, and Vancouver. The 170-hectare (420-acre) main Burnaby campus on Burnaby Mountain, located 15 kilometres (9.3 mi) from downtown Vancouver, was established in 1965 and comprises more than 30,000 students and 160,000 alumni. The university was created in an effort to expand higher education across Canada.
Burnaby is a city in the Lower Mainland region of British Columbia, Canada. Located in the centre of the Burrard Peninsula, it neighbours the City of Vancouver to the west, the District of North Vancouver across the confluence of the Burrard Inlet with its Indian Arm to the north, Port Moody and Coquitlam to the east, New Westminster and Surrey across the Fraser River to the southeast, and Richmond on the Lulu Island to the southwest.
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company.
The British Columbia Institute of Technology, is a public polytechnic institute in Burnaby, British Columbia. The technical institute has five campuses located in the Metro Vancouver region, with its main campus in Burnaby, British Columbia, Canada. There is also the Aerospace Technology Campus in Richmond, the Marine Campus in the City of North Vancouver, Downtown campus in Vancouver, and Annacis Island Campus in Delta. It is provincially chartered through legislation in the College and Institute Act. The school operates as a vocational and technical school, offering apprenticeships for the skilled trades and diplomas and degrees in vocational education for skilled technicians and workers in professions such as engineering, accountancy, business administration, broadcast/media communications, digital arts, nursing, computing, medicine, architecture, and law.
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen's Thousand Oaks staff in 2022 numbered approximately 5,000 and included hundreds of scientists, making Amgen the largest employer in Ventura County. As of 2022, Amgen has approximately 24,000 staff in total.
Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Science World is a science centre run by a not-for-profit organization called ASTC Science World Society in Vancouver, British Columbia, Canada. It is located at the end of False Creek and features many permanent interactive exhibits and displays, as well as areas with varying topics throughout the years.
Tak Wah Mak, is a Canadian medical researcher, geneticist, oncologist, and biochemist. He first became widely known for his discovery of the T-cell receptor in 1983 and pioneering work in the genetics of immunology. In 1995, Mak published a landmark paper on the discovery of the function of the immune checkpoint protein CTLA-4, thus opening the path for immunotherapy/checkpoint inhibitors as a means of cancer treatment. Mak is also the founder of Agios Pharmaceuticals, whose lead compound, IDHIFA®, was approved by the FDA for acute myeloid leukemia in August 2017, becoming the first drug specifically targeting cancer metabolism to be used for cancer treatment. He has worked in a variety of areas including biochemistry, immunology, and cancer genetics.
Geron Corporation is a biotechnology company located in Foster City, California, which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
BC Research Inc. is a privately owned Canadian process technology incubator, specializing in custom research, process development and technology commercialization. Headquartered in downtown Vancouver, British Columbia, BC Research operates primarily from their "Technology Commercialization and Innovation Centre" on Mitchell Island in the Vancouver suburb of Richmond. This 40,000 sq-ft facility includes a 28,000 sq-ft pilot plant development area, 2,500 sq-ft laboratory space, 9,000 sq-ft of office space, as well as a small machine shop and fenced outdoor piloting space. Technologies are scaled up from concept to pilot or demonstration scale in preparation for commercialization. Engineering support is provided by parent company NORAM Engineering and Constructors Ltd, which specializes in process development and commercialization in six industrial business areas with plant installations in Canada and abroad.
Connie Jean Eaves, CorrFRSE, is a Canadian biologist with significant contributions to cancer and stem cell research. Eaves is a professor generics of genetics at the University of British Columbia and is also the co-founder with Allen C Eaves of Terry Fox Laboratory.
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, USA, and Genmab K.K. in Tokyo, Japan. Genmab is a dual-listed company with shares traded on both the Copenhagen Stock Exchange in Denmark and the NASDAQ Global Select Market in the US.
Patrick Soon-Shiong is a South African-American transplant surgeon, billionaire businessman, bioscientist, and media proprietor. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer. Soon-Shiong is the founder of NantWorks, a network of healthcare, biotech, and artificial intelligence startups; an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles; and a visiting professor at Imperial College London and Dartmouth College. Soon-Shiong has published more than 100 scientific papers and has more than 230 issued patents worldwide on advancements spanning numerous fields in technology and medicine.
The Stem Cell Network (SCN) is a Canadian non-profit that supports stem cell and regenerative medicine research, teaches the next generation of highly qualified personal, and delivers outreach activities across Canada. The Network has been supported by the Government of Canada, since inception in 2001. SCN has catalyzed 25 clinical trials, 21 start-up companies, incubated several international and Canadian research networks and organizations, and established the Till & McCulloch Meetings, Canada's foremost stem cell research event.
Allen Charles Edward Eaves is the founding Director of the Terry Fox Laboratory for Hematology/Oncology Research, which over a 25-year period (1981–2006) he grew into an internationally recognized centre for the study of leukemia and stem cell research. His own research on chronic myelogenous leukemia (CML) has led the way to a new understanding of the disease. As Head of Hematology at the British Columbia Cancer Agency and the University of British Columbia for 18 years (1985–2003) he engineered the building of one of the first and largest bone marrow transplant programs in Canada. In recognition of his research accomplishments and leadership in moving basic science discoveries in stem cell biology into the clinic, he was elected President of the International Society of Cellular Therapy (1995–1997), Treasurer of the Foundation for the Accreditation of Cellular Therapy (1995–2002) and President of the American Society of Blood and Marrow Transplantation (1999–2000). In 2003 he was awarded the prestigious R. M. Taylor Medal by the Canadian Cancer Society and the National Cancer Institute of Canada.
Chung Hyung-min is a South Korean biotechnology professor. He was appointed professor at CHA University in 1997 after obtaining his BA, MA and Ph.D degree at Konkuk University.
McMaster Innovation Park (MIP) is an innovation and research facility located approximately two kilometres east of McMaster University in Hamilton, Ontario. McMaster Innovation Park focuses on supporting startups, business, research through providing property management services as well as business aid. Entrepreneurs, firms, researchers, industry partners, business mentors and support facilities are the main customers of the firm. MIP currently houses five buildings: the Atrium@MIP, CanmetMATERIALS, McMaster Automotive Resource Centre (MARC), Biomedical Engineering and Advanced Manufacturing (BEAM) project centre and envisions 10 buildings on site within 10 years with 1,500–1,800 people working full-time.
Jane Jae Kyung Shin is a Canadian academic and former politician who was elected to the Legislative Assembly of British Columbia in the 2013 provincial election. She is currently the Vice-President, Students & Community Development at Vancouver Community College.
Kite Pharma is an American biotechnology company that develops cancer immunotherapy products, with a primary focus on genetically engineered autologous CAR T cell therapy, a cell-based therapy which relies on chimeric antigen receptors and T cells. Founded in 2009, and based in Santa Monica, California, it was acquired by Gilead Sciences in 2017.
Lynne Quarmby is a Canadian scientist, activist, and politician. She is a professor and Chair of the Department of Molecular Biology and Biochemistry at Simon Fraser University in Burnaby, British Columbia. She was a candidate for the Green Party of Canada in Burnaby North—Seymour in the 2015 federal election, and is the Green Party of Canada's Science Policy Critic.
